FDA Will Convene Advisory Committee For COVID-19 Vaccine Decisions

FDA Commissioner Stephen Hahn and biologics center director Peter Marks say they plan to convene the agency’s vaccines advisory committee to review any COVID-19 vaccine, whether it be for emergency use authorization or licensure. Holding a public discussion is essential given the widespread potential use of a COVID-19 vaccine and the need for transparency, Hahn and Marks wrote in a Friday (Aug. 7) Journal of the American Medical Association article. During a Reagan-Udall Foundation for the FDA stakeholder call...